Guendulain VB, Vera NSA, Moreno MLG

Language: Spanish
References: 5
Page: 29-32
PDF size: 184.08 Kb.

ABSTRACT

The cutaneous manifestations of COVID-19 are not considered frequent and, rarely described. We present the case of a 44-year-old male, with no significant medical history, who was hospitalized for severe pneumonia secondary to SARS-COV-2 infection. On the 17th day of evolution of his respiratory symptoms, he started with acute disseminated dermatosis on the thorax and extremities, with erythema multiforme confirmed by skin biopsy. After receiving treatment with systemic and topical steroids, significant improvement was noticed. There is still much to study regarding COVID-19, but knowing how to recognize the extrapulmonary clinical alterations of this entity, can help to detect it properly and thus, provide medical early management.

REFERENCES

1. Bonilla-Arcaute LA, Posn Taracena JE, Barrón Tapia MT y Cruz PeñaM, Eritema multiforme en una paciente covid-19, Dermatología RevistaMexicana 2020; 4:491-5.

2. Feldman S y Freeman E, Cutaneous manifestations and issues relatedto dermatologic care, UpToDate 2020; 1-24.

3. Haussmann O y Schnyder WJ, Etiology and pathogenesis of adversedrug reactions, Chem Inmunol Allergy 2012; 32-46.

4. Jiménez-Cauh J, Ortega-Quijano D, Carretero-Barrio I, Suárez-ValleA y Saceda-Corralo A, Erythema multiforme-like eruption in patientswith covid-19 infection: clinical and histological findings, Clin Exp Dermatol2020; 892-5.

5. Wetter DA, Erythema multiforme: pathogenesis, clinical features, anddiagnosis, UpToDate 2019.